专题：Pharmaceutical Economics and Policy

This cluster of papers explores the economics of pharmaceutical research and development, focusing on topics such as drug development costs, generic drugs, pharmaceutical innovation, medicine prices, patent expiry, healthcare policies, market size, availability of medicines, and generic substitution.
最新文献
Changes in Medicare Part D Plan Designs After the Inflation Reduction Act

article Full Text OpenAlex

Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis

article Full Text OpenAlex

Moderate-Intensity Atorvastatin and Ezetimibe Combination Therapy Versus High-Intensity Atorvastatin in Patients with Angina Pectoris who Underwent Percutaneous Coronary Intervention

article Full Text OpenAlex

Global burden on drug use disorders from 1990 to 2021 and projections to 2046

article Full Text OpenAlex

IMPLEMENTATION OF AN ANTIBIOTIC RESTRICTION FORMULARY AND THE IMPACT ON CONSUMPTION IN A ROMANIAN HOSPITAL: A THREE-YEAR RETROSPECTIVE STUDY

article Full Text OpenAlex

Post-marketing safety signals of anifrolumab in systemic lupus erythematosus: a pharmacovigilance study based on FAERS

article Full Text OpenAlex

Regulating nanomedicines: challenges, opportunities, and the path forward

review Full Text OpenAlex

Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050

article Full Text OpenAlex

Stability of Drugs and Dosage Forms

book-chapter Full Text OpenAlex

Integrated Digital Biodata Infrastructure As A Catalyst For Systemic Healthcare Reform In Nigeria

article Full Text OpenAlex

近5年高被引文献
Vaccines safety case studies

book-chapter Full Text OpenAlex 332 FWCI87.844

Patients’ beliefs toward generic medication in Yemen

article Full Text OpenAlex 312 FWCI54.373

Knowledge, Beliefs and Factors Affecting the Use of Generic Medicines among Patients in Ibb, Yemen: A Mixed-method Study

article Full Text OpenAlex 303 FWCI52.804

Patients’ beliefs towards generic medicines in the United Arab Emirates

article Full Text OpenAlex 300 FWCI52.107

World Health Organization model list of essential medicines for children – 8th list, 2021

article Full Text OpenAlex 295 FWCI107.434

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment

review Full Text OpenAlex 260 FWCI12.681

Polypill Strategy in Secondary Cardiovascular Prevention

article Full Text OpenAlex 255 FWCI59.527

Improving data on pharmaceutical expenditure in hospitals and other health care settings

report Full Text OpenAlex 254 FWCI0

A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions

review Full Text OpenAlex 248 FWCI14.001

Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

article Full Text OpenAlex 234 FWCI105.466